CNXU Conexeu Sciences Inc.
$2.93▼ -0.24%
Healthcare
Other
Volume 148.7K
Avg Volume (10D) 477.1K
Key Metrics & Fundamentals
Market Cap
$90.43M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.83 - 18.79
% vs 50 MA
-40.64%
% vs 200 MA
–%
RSI-14
38.2
MACD Histogram
+0.0600
Beta (1Y vs SPY)
1.48
Free Cash Flow
-$6.80M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$7.64M
COGS
–
Operating Exp
$7.69M
Operating Income
-$7.69M
EBIT
-$7.69M
Pretax Income
-$7.73M
Net Income
-$7.73M
EPS (Diluted)
-0.29
Price & Volume History
Loading chart…
Recent News
Conexeu Sciences Closes $5 Million Private Placement
MT Newswires · Oct 15, 2026 5:20 PM ET
Conexeu Sciences Announces $5 Million Private Placement Led by Existing Shareholders, Management and Directors
GlobeNewswire · Oct 15, 2026 4:30 PM ET
Conexeu Sciences Advances Ten Minute Tissue™ Toward Planned FDA 510(k) Submission
GlobeNewswire · Oct 6, 2026 8:30 AM ET
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture
CNW Group · Sep 1, 2026 11:37 AM ET
Conexeu Sciences Sets September and October 2026 Conference Schedule
GlobeNewswire · Sep 1, 2026 8:30 AM ET
Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration
GlobeNewswire · Aug 18, 2026 8:30 AM ET
Conexeu to Present at 2026 Controversies & Conversations in Laser & Cosmetic Surgery Symposium on the Role of the Extracellular Matrix in Tissue Regeneration
GlobeNewswire · Aug 11, 2026 8:30 AM ET
Next GLP-1 Billion-Dollar Market: Fireside Chat with Conexeu Sciences CEO Miles Harrison
IPO-Edge.com · Aug 3, 2026 10:55 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CNXU's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.